I-Ibandronate Sodium CAS:138844-81-2 Umkhiqizi Womhlinzeki
I-sodium ye-Ibandronate isetshenziselwe ukutadisha umphumela wayo ekwandeni kanye ne-ultrastructure ye-Leishmania ne-Giardia ngokwenziwa kwamajika okuhlushwa.Iphinde isetshenziselwe ukucacisa umzila lapho i-nitrogen-containing bisphosphonates (N-BPs) ingena khona ku-cytosol futhi ivimbele i-molecular target yabo.I-sodium ye-Ibandronate ivimbela i-farnesyl diphosphate synthase (IC50 = 20 nM).I-Ibandronate sodium nayo iyi-bone resorption inhibitor.Kuye kwaphenywa ngemiphumela ye-in vitro anti-tumor, efana nokungeniswa kwe-apoptosis, inhibitor of cell growth, inhibitor of invasive behavior, kanye nokuvinjwa kwe-angiogenesis kanye nendima yayo ye-vivo kumdlavuza ohlukahlukene ohlanganisa umdlavuza webele nowe-prostate.
| Ukwakheka | I-C9H24NNaO7P2 |
| Isivivinyo | 99% |
| Ukubukeka | Impushana emhlophe |
| Inombolo ye-CAS. | 138844-81-2 |
| Ukupakisha | 25KG |
| I-Shelf Life | iminyaka engu-2 |
| Isitoreji | Gcina endaweni epholile neyomile |
| Isitifiketi | ISO. |
Bhala umyalezo wakho lapha futhi usithumelele wona








